GE HealthCare stock gains support from BTIG's USD 79 target
Published on 09/18/2026 at 20:00 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
GE HealthCare stock (ISIN US36266G1076) closed at USD 63.49 on September 16, 2026, after BTIG kept a Buy rating and a USD 79.00 price target on September 17, 2026. That leaves the shares about 24 percent below the target and roughly 22 percent below the start of 2026 level cited in the same note by ad hoc news.
Analyst targets remain above the market
BTIG's September 17, 2026 call cited positive feedback for GE HealthCare's next-generation photon-counting CT system and a solid imaging order backdrop, according to ad hoc news. The same report said the stock ended September 16, 2026 at USD 63.49, which frames the gap to BTIG's USD 79.00 target.
Metzler added a second bullish read-through on September 18, 2026, modeling 2026 order intake growth of 6.0 percent and a book-to-bill ratio of 1.07, while leaving its price target at EUR 74.00, according to ad hoc news. The comparison matters because a book-to-bill above 1.0 usually points to demand still running ahead of recognized revenue.
Price stays below target
On September 17, 2026, GE HealthCare traded between USD 62.99 and USD 65.25, with volume of 4.51 million shares and a 52-week range of USD 58.75 to USD 89.77, according to Investing.com. The close at USD 64.44 on that session left the stock in the upper half of its yearly band.
Trading range stays relevant
GE HealthCare closed at USD 64.44 on September 17, 2026, up 1.50 percent on the day, while the 52-week high remained USD 89.77. For investors, the gap to the broker targets is still the clearest number in the setup.
GE HealthCare at a glance
- Company: GE HealthCare Technologies Inc.
- ISIN: US36266G1076
- Ticker: GEHC
- Trading venue: NYSE
- Price (as of September 17, 2026): USD 64.44
- Market capitalization: USD 29.4 billion (as of September 17, 2026)
- Sector / Industry: Health Care Equipment & Supplies
- Index membership: S&P 500
